Dr Pamela Tenaerts, Executive Director of the USA Clinical Trials Transformation Initiative (CTTI), has highlighted the importance of engaging patient and sites early and often throughout a clinical trial.
CTTI released recommendations earlier this month for incorporating mobile technologies in clinical trials—labelling patient and site perspectives as critical for maximising success and minimising challenges.
“The use of mobile technologies holds the promise and potential for higher quality, more efficient clinical trials,” Dr Tenaerts said.
Dr Pamela Tenaerts will be presenting in the second plenary of the ACTA International Clinical Trials Conference, on Revolutions in Clinical Trials, where she will talk about mobile technology in clinical trial design. To find out more go to the Conference Program.